Another New Dawn

More than one way to skin a cat.

I am interested in discussing a few points such as future capital raises to propel manufacturing forward- potential other indications that trials could commence for - repricing of Rex- l to triple/ quadruple earlier Back pain guidance. I wonder also how that translates to CHF.

All this is hypothetical and co
ntingent upon BLA acceptance and subsequent approval of REM-l.

But first - future cap raises - I had thought the substantial income stream would provide enough cash. Yet a strategy to
raise capital has me asking a few questions.
Would these potential capital raises be offered to all shareholders at a discount to the prevailing price?
Us punters have missed the latest raises.
What dollars could we be talking to get to 3D?
I thought Lonza or similar would bear the brunt of these developments?

Would be nice to chat here without the three stooges commentary- I no longer see that circus- will turn back on once advised of the resubmission.

A good morning to you all

I am Eternally grateful for all your input


Reg